Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2026)

Alvotech (ALVO) posted Non-Current Deferred Tax Liability of $7.2 million for Q1 2026, down 8.95% on a QoQ basis from $7.9 million in Q4 2025, and up 248.1% year-over-year from $2.1 million in Q1 2025.

Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

Alvotech's Non-Current Deferred Tax Liability history runs 7 years deep, the most recent figure standing at $7.2 million for Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 248.1% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (up 248.1% YoY) and the FY2025 annual result came in at $7.9 million, up 334.46% from the prior year.
  • Non-Current Deferred Tax Liability was $7.2 million for Q1 2026 at Alvotech, down from $7.9 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $7.9 million in Q4 2025 and bottomed at $45000.0 in Q2 2023.
  • A 5-year average of $2.4 million and a median of $1.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability tumbled 82.85% — and 2024, when it soared 3316.98%.
  • Alvotech's Non-Current Deferred Tax Liability stood at $309000.0 in 2022, then tumbled by 82.85% to $53000.0 in 2023, then surged by 3316.98% to $1.8 million in 2024, then surged by 334.46% to $7.9 million in 2025, then dropped by 8.95% to $7.2 million in 2026.
  • Business Quant data shows ALVO's Non-Current Deferred Tax Liability at $7.2 million in Q1 2026, $7.9 million in Q4 2025, and $7.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.16 Mn
Mar 31, 2026 7.16 Mn
Dec 31, 2025 7.87 Mn
Dec 31, 2025 7.87 Mn
Sep 30, 2025 7.54 Mn
Sep 30, 2025 7.54 Mn
Jun 30, 2025 2.01 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 2.06 Mn
Mar 31, 2025 2.06 Mn
Dec 31, 2024 1.81 Mn
Dec 31, 2024 1.81 Mn
Sep 30, 2024 1.54 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.39 Mn
Jun 30, 2024 1.39 Mn
Mar 31, 2024 1.61 Mn
Mar 31, 2024 1.61 Mn
Dec 31, 2023 53,000.00
Dec 31, 2023 53,000.00